Brief: Idera Pharmaceuticals Says Cristina Csimma And Michael Dougherty Appointed To Board
10/04/2019 12:54
April 10 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS PROVIDES CORPORATE UPDATE
* IDERA PHARMACEUTICALS INC - CRISTINA CSIMMA AND MICHAEL
DOUGHERTY HAVE BEEN APPOINTED TO BOARD
Source text for Eikon: ID:nGNXCZcw2
Further company coverage: IDRA.O
((Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary